BIOCRYST PHARMACEUTICALS, INC. Deferred Tax Liabilities, Unrealized Currency Transaction Gains
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Deferred Tax Liabilities, Unrealized Currency Transaction Gains of $231.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-13.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains · last filed 2020-03-13
- 2018-12-31: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $231.00K.
- 2017-12-31: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $478.00K.
- 2016-12-31: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $1.42M.
- 2015-12-31: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $2.67M.
| Period end | Deferred Tax Liabilities, Unrealized Currency Transaction Gains |
|---|---|
| 2018-12-31 | $231.00K 10-K · filed 2020-03-13 |
| 2017-12-31 | $478.00K 10-K · filed 2019-03-14 |
| 2016-12-31 | $1.42M 10-K · filed 2018-03-12 |
| 2015-12-31 | $2.67M 10-K · filed 2017-02-27 |
| 2014-12-31 | $2.29M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |